Stay updated on Pembrolizumab & Blinatumomab in ALL Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Blinatumomab in ALL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Blinatumomab in ALL Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    No Change Detected
  3. Check
    14 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.5 to v3.6.6, indicating a minor maintenance update.
    Difference
    0.1%
    Check dated 2026-08-30T21:57:32.000Z thumbnail image
  4. Check
    21 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    Page revision tag changed from v3.6.4 to v3.6.5 on the study details page. This reflects a minor backend/content-management update and does not alter the study information presented.
    Difference
    0.1%
    Check dated 2026-08-09T11:26:58.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The bottom revision tag was updated from Revision: v3.6.3 to Revision: v3.6.4, indicating a minor behind-the-scenes update. This does not affect the study details or user-facing content.
    Difference
    0.1%
    Check dated 2026-07-25T18:15:52.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    The page shows a new site revision (v3.6.3) replacing the previous v3.6.2. This indicates a software update rather than changes to the study content.
    Difference
    0.1%
    Check dated 2026-07-04T13:21:11.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.0 to v3.6.2, indicating a minor internal update to the page version. The underlying content and study details appear unchanged.
    Difference
    0.1%
    Check dated 2026-06-27T05:41:48.000Z thumbnail image
  9. Check
    93 days ago
    Change Detected
    Summary
    New help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) have been added, and a recruitment status note indicates no longer looking for participants. The Interventions header has been standardized to Intervention/Treatment, and the revision tag has been updated from v3.5.5 to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-13T05:11:20.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Blinatumomab in ALL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Blinatumomab in ALL Clinical Trial page.